
Primevision Pharma Llp
Pharmaceutical company specializing in manufacturing, formulating, and distributing various healthcare products.
Pharmaceutical company specializing in manufacturing, formulating, and distributing various healthcare products.
Primevision Pharma Llp (PPL) is 3 Year, 1 Month old Limited Liability Partnership 01 February 2022. Its registered office is in Sangli, Maharashtra, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 2.00 Cr as per MCA.
Sangli, Maharashtra, India
+91-XXXXXXXXXX
-
ABA-4515
01 Feb 2022
31 Mar 2023
Roc-Pune
Limited Liability Partnership
Name | Designation | Appointment Date | Status |
---|---|---|---|
Niranjan Patil ![]() | Designated Partner | 01-Feb-2022 | Current |
Chetan Sankh ![]() | Designated Partner | 18-Mar-2022 | Current |
Yogesh Mirji ![]() | Designated Partner | 18-Mar-2022 | Current |
Rajendrakumar Dhanavade ![]() | Designated Partner | 18-Mar-2022 | Current |
Vijay Magdum ![]() | Designated Partner | 18-Mar-2022 | Current |
Ashishkumar Kore ![]() | Designated Partner | 01-Feb-2022 | Current |
Enhance accessibility to Primevision Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Primevision Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Niranjan Patil is a mutual person
Yogesh Mirji is a mutual person
₹12.30 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
08 Jul 2022 | Bank Of India | ₹12.30 Cr | Open |
Unlock and access historical data on people associated with Primevision Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Primevision Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Primevision Pharma Llp's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Primevision Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with RoC-Pune.
A charge with Bank Of India amounted to Rs. 12.30 Cr with Charge ID 100632630 was registered on 08 Jul 2022.
Chetan Suresh Sankh was appointed as a Designated Partner was appointed as a Designated Partner on 18 Mar 2022 & has been associated with this company since 2 years 11 months .
Yogesh Veerabhadra Mirji was appointed as a Designated Partner was appointed as a Designated Partner on 18 Mar 2022 & has been associated with this company since 2 years 11 months .
Rajendrakumar Bhagvant Dhanavade was appointed as a Designated Partner was appointed as a Designated Partner on 18 Mar 2022 & has been associated with this company since 2 years 11 months .
Vijay Kallappa Magdum was appointed as a Designated Partner was appointed as a Designated Partner on 18 Mar 2022 & has been associated with this company since 2 years 11 months .
Primevision Pharma Llp was incorporated on 01 Feb 2022.
The Obligation of Contribution of Primevision Pharma Llp is ₹ 2.00 Cr.
Currently 7 partners are associated with Primevision Pharma Llp.
As per Ministry of Corporate Affairs (Mca), the registered address of Primevision Pharma Llp is Plot No. 28; Flat 206; Nirmiti Tower Near Dr. Sanjeev Kulkarni Hospital, Na Miraj, Sangli, Maharashtra, India, 416410.
The Limited Liability Partnership Identification Number (LLPIN) of Primevision Pharma Llp is ABA-4515.
As per the financial statements for fiscal Year 0, The total open charges for Primevision Pharma Llp amount to ₹ 12.30 Cr.
The most recent Balance Sheet for Primevision Pharma Llp was filed with the ROC on 31 Mar 2023.